NEW YORK, Dec 19 (Reuters) - Idera Pharmaceuticals Inc on Wednesday said it had agreed to a partnership under which it will license technology to German drugmaker Merck KGaA for cancer treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results